US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

PMGC Holdings

1.89

-0.0250-1.31%

Post-market: 1.940.0550+2.92%19:59 EDT

Volume:11.61K

Turnover:22.13K

Market Cap:2.59M

PE:-0.06

High:1.93

Open:1.91

Low:1.88

Close:1.91

Loading ...

Overview Company News Filings

ELEVAI Labs Inc. Enters New Secondment Agreement

PMGC Holdings Inc. Enters into Secondment Agreement with Northstrive Companies Inc

Northstrive Biosciences, a Subsidiary of PMGC Holdings, Signs Term Sheet with Modulant for EL-22 Animal Health Licensing

Northstrive Biosciences Strengthens IP Portfolio with New US Patent Filings for EL-22 and EL-32 Programs Covering Obesity and Animal Health

Northstrive Biosciences Co-Founder Featured on Bear Bull Traders Following Announcement of Positive FDA Response Supporting Submission of IND for EL-22 Phase 2 Clinical Trial

BRIEF-PMGC Holdings Enters Sales Agreement With Univest Securities

BRIEF-Northstrive Biosciences Announces Positive FDA Response Supporting A Submission Of IND For A Phase 2 Clinical Trial For EL-22 In Combination With GLP-1 Receptor Agonist For Obesity Treatment

Northstrive Biosciences Announces Positive FDA Response Supporting A Submission of IND for a Phase 2 Clinical Trial for EL-22 in Combination with GLP-1 Receptor Agonist for Obesity Treatment

PMGC Holdings Announces Acquisition of IT Packaging Firm

PMGC Signs Letter of Intent to Purchase Custom IT Packaging Firm; Shares Fall

MT Newswires Live

PMGC Holdings Inc. Signs Letter of Intent to Acquire Profitable U.S.-Based Custom IT Packaging Company

Northstrive Biosciences Signs Partnership with Yuva Biosciences to Develop AI-Powered Therapies for Obesity and Cardiometabolic Diseases

PMGC Holdings Inc. Announces Filing of Annual Report on Form 10-K

NorthStrive Biosciences Inc. Signs Amended Licensing Agreement with Existing Licensor, Aims to Capture Animal Health Market

PMGC Holdings Inc trading resumes

BRIEF-PMGC Holdings Announces $1.48 Million Registered Direct Offering Priced At-The Market Under Nasdaq Rules

PMGC Holdings Inc trading halted, volatility trading pause

ELEVAI Labs Inc. Considers Further Share Repurchases

PMGC Holdings Announces Share Repurchases from Existing Shareholders

BRIEF-Northstrive Biosciences plans meeting with FDA for its new obesity reducing therapy

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ELAB/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ELAB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ELAB\",,,,,undefined,":{"symbol":"ELAB","market":"US","secType":"STK","nameCN":"PMGC Holdings","latestPrice":1.885,"timestamp":1754596800000,"preClose":1.91,"halted":0,"volume":11606,"hourTrading":{"tag":"盘后","latestPrice":1.94,"preClose":1.885,"latestTime":"19:59 EDT","volume":209,"amount":405.2001,"timestamp":1754611169211},"delay":0,"floatShares":1259304,"shares":1375385,"eps":-30.362034,"marketStatus":"Closed","change":-0.025,"latestTime":"08-07 16:00:00 EDT","open":1.91,"high":1.93,"low":1.88,"amount":22125.8165114,"amplitude":0.026178,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-30.362034,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1754640000000},"marketStatusCode":5,"adr":0,"listingDate":1700542800000,"exchange":"NASDAQ","adjPreClose":1.91,"preHourTrading":{"tag":"盘前","latestPrice":1.91,"preClose":1.93,"latestTime":"08:00 EDT","volume":10,"amount":19.099999999999998,"timestamp":1754568000110},"postHourTrading":{"tag":"盘后","latestPrice":1.94,"preClose":1.885,"latestTime":"19:59 EDT","volume":209,"amount":405.2001,"timestamp":1754611169211},"volumeRatio":0.271889},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ELAB\",,,,,undefined,":{"symbol":"ELAB","floatShares":1259304,"roa":"-36.92%","roe":"-95.21%","lyrEps":-78.481779,"volumeRatio":0.271889,"shares":1375385,"dividePrice":0,"high":1.93,"amplitude":0.026178,"preClose":1.91,"low":1.88,"week52Low":1.81,"pbRate":"0.32","psRate":"1.06","week52High":546,"institutionHeld":0,"latestPrice":1.885,"eps":-30.362034,"divideRate":0,"volume":11606,"delay":0,"ttmEps":-30.362034,"open":1.91,"prevYearClose":16.03,"prevWeekClose":1.95,"prevMonthClose":2.09,"prevQuarterClose":2.16,"fiveDayClose":2.09,"twentyDayClose":2.27,"sixtyDayClose":2.39},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ELAB\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2535033937","title":"ELEVAI Labs Inc. Enters New Secondment Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2535033937","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535033937?lang=en_us&edition=fundamental","pubTime":"2025-05-14 05:16","pubTimestamp":1747171000,"startTime":"0","endTime":"0","summary":"ELEVAI Labs Inc. ( ($ELAB) ) just unveiled an announcement. On May 7, 2025, PMGC Holdings Inc. entered into a Secondment Agreement with Northstrive...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/elevai-labs-inc-enters-new-secondment-agreement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/elevai-labs-inc-enters-new-secondment-agreement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4183","ELAB"],"gpt_icon":0},{"id":"2535817080","title":"PMGC Holdings Inc. Enters into Secondment Agreement with Northstrive Companies Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2535817080","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535817080?lang=en_us&edition=fundamental","pubTime":"2025-05-14 04:51","pubTimestamp":1747169499,"startTime":"0","endTime":"0","summary":"PMGC Holdings Inc. has announced a new contractual agreement with Northstrive Companies Inc., a California-based corporation. The agreement, effective as of May 7, 2025, involves Northstrive seconding certain employees to PMGC Holdings to provide specified services. These employees will remain on Northstrive's payroll while delivering services to PMGC Holdings. The agreement outlines details regarding employee responsibilities, location of service provision, and termination procedures. It also includes standard provisions related to confidentiality and liability. This strategic collaboration aims to enhance operational efficiency and service delivery for PMGC Holdings.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PMGC Holdings Inc. p","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nNDLw06YJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELAB","BK4183"],"gpt_icon":0},{"id":"2535727969","title":"Northstrive Biosciences, a Subsidiary of PMGC Holdings, Signs Term Sheet with Modulant for EL-22 Animal Health Licensing","url":"https://stock-news.laohu8.com/highlight/detail?id=2535727969","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535727969?lang=en_us&edition=fundamental","pubTime":"2025-05-13 20:00","pubTimestamp":1747137635,"startTime":"0","endTime":"0","summary":"Northstrive Biosciences Inc., a subsidiary of PMGC Holdings Inc., has announced a significant collaboration with Modulant Biosciences LLC. The two companies have signed a binding term sheet that grants Modulant exclusive global rights to develop and commercialize EL-22, a pioneering probiotic approach aimed at muscle preservation in livestock. This strategic partnership allows Northstrive to monetize its intellectual property in the animal health sector. If successfully developed and brought to market, EL-22 could become a long-term revenue-generating asset. The agreement also outlines that Modulant will share a portion of revenues from sublicensing and commercial activities with Northstrive, with specified royalty rates. The parties plan to finalize the definitive licensing agreement in the coming months, pending necessary approvals.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timel","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nNDL3pwy1g:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","BK4183","LU2210149790.SGD","BK4112","LU2210150020.SGD","IE00B64PRP62.GBP","ELAB","BK4588","LU2095319765.USD","IE00BKPKM429.USD","BK4585"],"gpt_icon":0},{"id":"2531173250","title":"Northstrive Biosciences Strengthens IP Portfolio with New US Patent Filings for EL-22 and EL-32 Programs Covering Obesity and Animal Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2531173250","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531173250?lang=en_us&edition=fundamental","pubTime":"2025-04-29 20:00","pubTimestamp":1745928000,"startTime":"0","endTime":"0","summary":"NEWPORT BEACH, Calif., April 29, 2025  -- Northstrive Biosciences Inc. , a subsidiary of PMGC Holdings Inc.  , today announced the filing of four novel patent applications for its two candidates EL-22 and EL-32. These patent applications cover the animal market, as well as treating muscle loss in obese patients, both as standalone and combination therapies alongside GLP-1 receptor agonists.The Company filed the following four patents today:. EL-22 in Animals: Fusion Protein of Myo-2 for Use in Encouraging Muscle Growth in Animals .EL-32 in Obesity as Monotherapy and Combination with GLP-1: Updated patent filings for Pharmaceutical Composition for Treatment of Muscle Loss Due to Obesity Treatments , and Combination Therapy for Treatment of Muscle Loss Due to Obesity Treatments utilizing GLP-1 receptor agonists .“We believe that EL-22 and EL-32 have the potential to treat obesity in combination with GLP-1 receptor agonists, while also serving as the foundation to a potential range of ani","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/northstrive-biosciences-strengthens-ip-portfolio-120000070.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4558","BK4136","LU1481599808.USD","BK4588","EL","LU2463526074.USD","LU2552382058.USD","BK4533","LU1169590202.USD","BK4504","LU2552382215.SGD","LU2404859667.USD","LU1487256676.USD","BK4548","LU2552382132.HKD","LU0690374961.EUR","LU0690374615.EUR","BK4183","VAQC","BK4585","IE00B3T34201.USD","BK4561","LU1481600234.SGD","ELAB","IP","LU1169589451.USD","LU2404859741.USD"],"gpt_icon":0},{"id":"2530440591","title":"Northstrive Biosciences Co-Founder Featured on Bear Bull Traders Following Announcement of Positive FDA Response Supporting Submission of IND for EL-22 Phase 2 Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2530440591","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530440591?lang=en_us&edition=fundamental","pubTime":"2025-04-28 20:00","pubTimestamp":1745841600,"startTime":"0","endTime":"0","summary":"NEWPORT BEACH, Calif., April 28, 2025  -- Northstrive Biosciences Inc. , a subsidiary of PMGC Holdings Inc.  , is proud to announce that Co-Founder Deniel Mero was recently featured in an exclusive interview hosted by Bear Bull Traders, a leading global online stock trading community for professional and aspiring traders.During the interview, Mr. Mero discussed Northstrive’s recent milestone: receiving preliminary meeting responses from the FDA regarding Northstrive’s nonclinical studies and clinical development plans for EL-22, administered in combination with GLP-1 receptor agonists. EL-22 is leveraging a myostatin-engineered probiotic approach to address obesity’s pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists.Bear Bull Traders is an international trading education community founded in 2015 by Andrew Aziz. With over 100,000 members globally, Bear Bull Traders offers comprehensive education, expert mentorship, and community supp","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/northstrive-biosciences-co-founder-featured-120000019.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["EL","LU2404859667.USD","LU2552382058.USD","LU2552382132.HKD","ELAB","BK4183","BK4558","BK4585","LU0690374615.EUR","BK4504","BK4533","BK4588","BK4548","LU2552382215.SGD","LU2404859741.USD","LU0690374961.EUR"],"gpt_icon":0},{"id":"2529592987","title":"BRIEF-PMGC Holdings Enters Sales Agreement With Univest Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2529592987","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529592987?lang=en_us&edition=fundamental","pubTime":"2025-04-24 20:57","pubTimestamp":1745499476,"startTime":"0","endTime":"0","summary":"BRIEF-PMGC Holdings Enters Sales Agreement With Univest SecuritiesApril 24  - PMGC Holdings Inc ELAB.O:PMGC HOLDINGS INC - ENTERS SALES AGREEMENT WITH UNIVEST SECURITIES - SEC FILINGPMGC HOLDINGS INC - TO ISSUE AND SELL UP TO $100 MILLION IN COMMON STOCK - SEC FILINGFurther company coverage: ELAB.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250424:nFWN3R225T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELAB"],"gpt_icon":0},{"id":"2529166989","title":"BRIEF-Northstrive Biosciences Announces Positive FDA Response Supporting A Submission Of IND For A Phase 2 Clinical Trial For EL-22 In Combination With GLP-1 Receptor Agonist For Obesity Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2529166989","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529166989?lang=en_us&edition=fundamental","pubTime":"2025-04-24 20:18","pubTimestamp":1745497096,"startTime":"0","endTime":"0","summary":"BRIEF-Northstrive Biosciences Announces Positive FDA Response Supporting A Submission Of IND For A Phase 2 Clinical Trial For EL-22 In Combination With GLP-1 Receptor Agonist For Obesity TreatmentApri","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250424:nTUA5MCKTP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELAB","BK4183"],"gpt_icon":0},{"id":"2529354269","title":"Northstrive Biosciences Announces Positive FDA Response Supporting A Submission of IND for a Phase 2 Clinical Trial for EL-22 in Combination with GLP-1 Receptor Agonist for Obesity Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2529354269","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529354269?lang=en_us&edition=fundamental","pubTime":"2025-04-24 20:00","pubTimestamp":1745496000,"startTime":"0","endTime":"0","summary":"Northstrive Biosciences received preliminary meeting responses from the FDA regarding Northstrive’s nonclinical studies and clinical development plans for EL-22, administered in combination with GLP-1 receptor agonists.Northstrive believes the FDA responses encourage a path forward for filing an IND application to conduct a Phase 2 clinical trial in overweight or obese patients.EL-22 is leveraging a myostatin-engineered probiotic approach to address obesity’s pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists.NEWPORT BEACH, Calif., April 24, 2025  -- Northstrive Biosciences Inc. , a subsidiary of PMGC Holdings Inc.  , announced that it has received preliminary responses and commentary from the U.S. Food and Drug Administration  regarding its scheduled Type B pre-Investigational New Drug  meeting. Northstrive initially requested this meeting with the FDA to discuss nonclinical studies and Northstrive Biosciences’ clinical development p","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/northstrive-biosciences-announces-positive-fda-120000281.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2552382215.SGD","LU2404859667.USD","LU0690374615.EUR","GLP","BK4504","BK4585","BK4558","LU2552382132.HKD","EL","BK4144","BK4590","BK4183","LU2552382058.USD","BK4588","LU0690374961.EUR","BK4548","LU2404859741.USD","BK4533","ELAB"],"gpt_icon":0},{"id":"2528926427","title":"PMGC Holdings Announces Acquisition of IT Packaging Firm","url":"https://stock-news.laohu8.com/highlight/detail?id=2528926427","media":"TIPRANKS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528926427?lang=en_us&edition=fundamental","pubTime":"2025-04-17 18:35","pubTimestamp":1744886104,"startTime":"0","endTime":"0","summary":"The latest update is out from ELEVAI Labs Inc. ( ($ELAB) ). On April 16, 2025, PMGC Holdings Inc. announced the signing of a non-binding Letter of ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pmgc-holdings-announces-acquisition-of-it-packaging-firm?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pmgc-holdings-announces-acquisition-of-it-packaging-firm?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4183","ELAB"],"gpt_icon":0},{"id":"2528221772","title":"PMGC Signs Letter of Intent to Purchase Custom IT Packaging Firm; Shares Fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2528221772","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528221772?lang=en_us&edition=fundamental","pubTime":"2025-04-17 00:19","pubTimestamp":1744820368,"startTime":"0","endTime":"0","summary":"PMGC Holdings  said Wednesday it has signed a non-binding letter of intent to buy an unnamed US-based information technology custom packaging firm.The target company has \"close to 15 years of uninterrupted operations\" and consistently delivered positive earnings before interest, taxes, depreciation, and amortisation performance year over year, PMGC said.PMGC said it expects to sign a definitive agreement and close the deal before the end of Q2, subject to customary conditions.The deal marks the launch of PMGC's previously announced acquisition strategy, the company said, adding this is the \"first of several accretive acquisitions shareholders can expect in the months ahead.\"Price: 2.51, Change: -0.40, Percent Change: -13.78","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ELAB","BK4183"],"gpt_icon":0},{"id":"2527290211","title":"PMGC Holdings Inc. Signs Letter of Intent to Acquire Profitable U.S.-Based Custom IT Packaging Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2527290211","media":"GlobeNewswire","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527290211?lang=en_us&edition=fundamental","pubTime":"2025-04-16 20:00","pubTimestamp":1744804800,"startTime":"0","endTime":"0","summary":"Acquisition Target Currently Serves over 300 Commercial Clients, which Includes Data Centers, Technology Manufacturers, and IT Service Providers with Close to 15 Years of Operational History, 90% U.S.-Based Revenue, and Recurring Business. NEWPORT BEACH, Calif., April 16, 2025  -- PMGC Holdings Inc.  , a diversified public holding company, is pleased to announce the signing of a non-binding Letter of Intent  to acquire a U.S.-based, cash-flow positive information technology  custom packaging company.Founded in 2011 and headquartered in Southern California, the Target is a well-established provider of custom packaging solutions for IT products, serving over 300 commercial clients—including data centers, technology manufacturers, and IT service providers. With close to 15 years of uninterrupted operations, the company has built a loyal, predominantly U.S.-based customer base (90%) and consistently delivered positive EBITDA performance year over year.The closing of this acquisition is sub","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pmgc-holdings-inc-signs-letter-120000669.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ELAB"],"gpt_icon":0},{"id":"2526631595","title":"Northstrive Biosciences Signs Partnership with Yuva Biosciences to Develop AI-Powered Therapies for Obesity and Cardiometabolic Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2526631595","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526631595?lang=en_us&edition=fundamental","pubTime":"2025-04-10 20:00","pubTimestamp":1744286400,"startTime":"0","endTime":"0","summary":"Northstrive Biosciences and Yuva Biosciences’ collaboration will leverage MitoNova, YuvaBio’s proprietary mitochondrial science-focused artificial intelligence platform, to discover and develop novel ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/04/10/3059185/0/en/Northstrive-Biosciences-Signs-Partnership-with-Yuva-Biosciences-to-Develop-AI-Powered-Therapies-for-Obesity-and-Cardiometabolic-Diseases.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ELAB"],"gpt_icon":0},{"id":"2522707575","title":"PMGC Holdings Inc. Announces Filing of Annual Report on Form 10-K","url":"https://stock-news.laohu8.com/highlight/detail?id=2522707575","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522707575?lang=en_us&edition=fundamental","pubTime":"2025-03-28 20:00","pubTimestamp":1743163200,"startTime":"0","endTime":"0","summary":"NEWPORT BEACH, Calif., March 28, 2025  -- PMGC Holdings Inc.   today announced that it has filed its Annual Report on Form 10-K  for the fiscal year ended December 31, 2024, with the U.S. Securities and Exchange Commission .The Annual Report is available on the SEC’s website at www.sec.gov under the company’s filings, as well as on the Company’s investor relations website.PMGC remains dedicated to innovative solutions and delivering long-term value for its shareholders. As part of its strategic growth initiatives, the Company has engaged in an active search for acquisition opportunities involving operating businesses and assets with the potential to drive meaningful revenue growth and enhance shareholder value.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pmgc-holdings-inc-announces-filing-120000755.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ELAB","BK4183"],"gpt_icon":0},{"id":"2522177372","title":"NorthStrive Biosciences Inc. Signs Amended Licensing Agreement with Existing Licensor, Aims to Capture Animal Health Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2522177372","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522177372?lang=en_us&edition=fundamental","pubTime":"2025-03-27 20:00","pubTimestamp":1743076800,"startTime":"0","endTime":"0","summary":"The U.S. animal health market was valued at USD 12.65 billion in 2024 and is expected to grow at a CAGR of 7.97% from 2025 to 2030. This growth is believed to be a consequence of rising innovations surrounding companion animal pharmaceuticals, increasing millennial pet adoption rates, growing livestock populations and production in developing countries, and increasing meat or milk consumption rates, coupled with rising concerns about food-borne diseases.Northstrive Biosciences Inc.’s amendment to its existing licensing agreement allows the company to develop and commercialize a comprehensive range of animal health products, including pharmaceuticals and feed additives. The company believes these products are essential for improving animal health, productivity, and overall food security.The Company believes this expanded scope of its license rights with MOA will position NorthStrive Biosciences to potentially capture new revenue streams from high-growth markets and lower its barrier to ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/northstrive-biosciences-inc-signs-amended-120000713.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4183","ELAB"],"gpt_icon":0},{"id":"2521554312","title":"PMGC Holdings Inc trading resumes","url":"https://stock-news.laohu8.com/highlight/detail?id=2521554312","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521554312?lang=en_us&edition=fundamental","pubTime":"2025-03-22 02:55","pubTimestamp":1742583307,"startTime":"0","endTime":"0","summary":"14:51 EDT PMGC (ELAB) Holdings Inc trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking financial ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pmgc-holdings-inc-trading-resumes-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pmgc-holdings-inc-trading-resumes-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ELAB","BK4183"],"gpt_icon":0},{"id":"2521548255","title":"BRIEF-PMGC Holdings Announces $1.48 Million Registered Direct Offering Priced At-The Market Under Nasdaq Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2521548255","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521548255?lang=en_us&edition=fundamental","pubTime":"2025-03-22 02:50","pubTimestamp":1742583056,"startTime":"0","endTime":"0","summary":"BRIEF-PMGC Holdings Announces $1.48 Million Registered Direct Offering Priced At-The Market Under Nasdaq RulesMarch 21 (Reuters) - PMGC Holdings Inc ELAB.O:PMGC HOLDINGS INC. ANNOUNCES $1.48 MILLION R","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250321:nTUA3TCZM7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ELAB"],"gpt_icon":0},{"id":"2521725543","title":"PMGC Holdings Inc trading halted, volatility trading pause","url":"https://stock-news.laohu8.com/highlight/detail?id=2521725543","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521725543?lang=en_us&edition=fundamental","pubTime":"2025-03-22 02:45","pubTimestamp":1742582708,"startTime":"0","endTime":"0","summary":"14:41 EDT PMGC (ELAB) Holdings Inc trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, market-m...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pmgc-holdings-inc-trading-halted-volatility-trading-pause-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pmgc-holdings-inc-trading-halted-volatility-trading-pause-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4183","ELAB"],"gpt_icon":0},{"id":"2521173289","title":"ELEVAI Labs Inc. Considers Further Share Repurchases","url":"https://stock-news.laohu8.com/highlight/detail?id=2521173289","media":"TIPRANKS","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521173289?lang=en_us&edition=fundamental","pubTime":"2025-03-21 20:53","pubTimestamp":1742561585,"startTime":"0","endTime":"0","summary":"ELEVAI Labs Inc. ( ($ELAB) ) has shared an announcement. On March 18, 2025, PMGC Holdings Inc. repurchased shares from existing shareholders who di...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/elevai-labs-inc-considers-further-share-repurchases?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/elevai-labs-inc-considers-further-share-repurchases?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4183","ELAB"],"gpt_icon":0},{"id":"2521730288","title":"PMGC Holdings Announces Share Repurchases from Existing Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2521730288","media":"GlobeNewswire","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521730288?lang=en_us&edition=fundamental","pubTime":"2025-03-21 20:00","pubTimestamp":1742558400,"startTime":"0","endTime":"0","summary":"NEWPORT BEACH, Calif., March 21, 2025  -- PMGC Holdings Inc.   today announced that it has repurchased shares from certain existing shareholders who contacted the Company directly. Details of these transactions are available in the Company’s Form 8-K filings on www.sec.gov.The Company will consider repurchasing additional shares from other investors who wish to sell, subject to market conditions and other considerations.Shareholders interested in discussing potential repurchases are encouraged to contact the Company directly in writing and mail request the company's headquarters in Newport Beach, California.This press release does not constitute an offer to purchase or a solicitation of an offer to sell any securities. The Company is not conducting a formal share repurchase program or tender offer. Any repurchases of shares referenced herein were made in response to unsolicited shareholder inquiries and may or may not occur in the future, at the Company’s sole discretion.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pmgc-holdings-announces-share-repurchases-120000365.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4183","ELAB"],"gpt_icon":0},{"id":"2518279097","title":"BRIEF-Northstrive Biosciences plans meeting with FDA for its new obesity reducing therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2518279097","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518279097?lang=en_us&edition=fundamental","pubTime":"2025-03-10 23:15","pubTimestamp":1741619706,"startTime":"0","endTime":"0","summary":"BRIEF-Northstrive Biosciences plans meeting with FDA for its new obesity reducing therapyMarch 10  - PMGC Holdings Inc ELAB.O:NORTHSTRIVE BIOSCIENCES INC. SCHEDULES PRE-IND MEETING WITH FDA FOR EL-22, AN OBESITY THERAPY TARGETING FAT LOSS AND MUSCLE PRESERVATION IN COMBINATION WITH GLP-1NORTHSTRIVE BIOSCIENCES : SCHEDULED A PRE-IND MEETING WITH U.S. FOOD AND DRUG ADMINISTRATION FOR APRIL 23, 2025Source text: nGNX7B0PkGFurther company coverage: ELAB.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nFWN3PT0PH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ELAB"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":57,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ELAB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-10","symbol":"ELAB","defaultRemindTime":1741613400000,"type":"split","dateTimestamp":1741579200000,"forFactor":7,"toFactor":1,"ratio":7},{"market":"US","date":"2024-11-27","symbol":"ELAB","defaultRemindTime":1732717800000,"type":"split","dateTimestamp":1732683600000,"forFactor":200,"toFactor":1,"ratio":200}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ELAB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ELAB\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ELAB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ELAB","date":"2025-08-06","current":-0.398326,"percent":0.891358,"low":-19.933298,"twenty":-3.111449,"median":-1.221257,"eighty":-0.470749,"high":-0.185003,"avg":-2.253177,"sd":3.018379,"marketCap":2571969},"quantilePoints":[{"date":"2023-11-24","current":-18.255744,"twenty":-17.959705,"median":-17.515646,"eighty":-17.071587,"marketCap":64119575},{"date":"2023-12-01","current":-13.864497,"twenty":-19.360956,"median":-18.255744,"eighty":-16.918634,"marketCap":48696218},{"date":"2023-12-08","current":-10.509387,"twenty":-18.255744,"median":-15.443372,"eighty":-11.703412,"marketCap":36912079},{"date":"2023-12-15","current":-8.308155,"twenty":-18.10279,"median":-11.940243,"eighty":-9.335099,"marketCap":31539899},{"date":"2023-12-22","current":-8.354717,"twenty":-17.34789,"median":-10.682077,"eighty":-8.450306,"marketCap":31716661},{"date":"2023-12-29","current":-8.216856,"twenty":-16.918634,"median":-10.164008,"eighty":-8.299025,"marketCap":31193307},{"date":"2024-01-05","current":-7.303872,"twenty":-15.709807,"median":-9.153506,"eighty":-8.280766,"marketCap":27727384},{"date":"2024-01-12","current":-8.125558,"twenty":-14.012516,"median":-8.832664,"eighty":-8.070779,"marketCap":30846714},{"date":"2024-01-19","current":-4.884465,"twenty":-13.479646,"median":-8.376629,"eighty":-7.906442,"marketCap":18542688},{"date":"2024-01-26","current":-3.42369,"twenty":-11.881035,"median":-8.330979,"eighty":-7.359564,"marketCap":12997211},{"date":"2024-02-02","current":-3.834533,"twenty":-11.486317,"median":-8.216856,"eighty":-4.738387,"marketCap":14556876},{"date":"2024-02-09","current":-2.921549,"twenty":-10.785691,"median":-8.079909,"eighty":-3.801666,"marketCap":11090953},{"date":"2024-02-16","current":-3.323718,"twenty":-10.440311,"median":-7.942961,"eighty":-3.414564,"marketCap":12617692},{"date":"2024-02-23","current":-3.218269,"twenty":-10.164008,"median":-7.897312,"eighty":-3.378041,"marketCap":12217378},{"date":"2024-03-01","current":-3.181749,"twenty":-9.179141,"median":-7.443102,"eighty":-3.218269,"marketCap":12078741},{"date":"2024-03-08","current":-3.378041,"twenty":-9.127872,"median":-4.975763,"eighty":-3.263918,"marketCap":12823915},{"date":"2024-03-15","current":-3.555616,"twenty":-8.855945,"median":-4.679044,"eighty":-3.323718,"marketCap":13498037},{"date":"2024-03-22","current":-3.491707,"twenty":-8.832664,"median":-3.834533,"eighty":-3.332848,"marketCap":13255422},{"date":"2024-03-28","current":-3.149795,"twenty":-8.668692,"median":-3.638241,"eighty":-3.254788,"marketCap":11957434},{"date":"2024-04-05","current":-2.739531,"twenty":-8.426843,"median":-3.539867,"eighty":-3.191975,"marketCap":11784138},{"date":"2024-04-12","current":-2.578785,"twenty":-8.359099,"median":-3.514988,"eighty":-3.15016,"marketCap":11092686},{"date":"2024-04-19","current":-2.356802,"twenty":-8.353987,"median":-3.494218,"eighty":-3.138017,"marketCap":10137824},{"date":"2024-04-26","current":-2.715358,"twenty":-8.317285,"median":-3.457927,"eighty":-2.966103,"marketCap":11680160},{"date":"2024-05-03","current":-2.840249,"twenty":-8.271636,"median":-3.430537,"eighty":-2.908834,"marketCap":12217378},{"date":"2024-05-10","current":-2.751214,"twenty":-8.225986,"median":-3.400866,"eighty":-2.810275,"marketCap":11834394},{"date":"2024-05-17","current":-2.439543,"twenty":-8.198597,"median":-3.378041,"eighty":-2.734696,"marketCap":11265982},{"date":"2024-05-24","current":-2.476318,"twenty":-8.139253,"median":-3.346086,"eighty":-2.649774,"marketCap":11435812},{"date":"2024-05-31","current":-2.456058,"twenty":-8.070779,"median":-3.333761,"eighty":-2.615446,"marketCap":11342250},{"date":"2024-06-07","current":-2.620224,"twenty":-8.03426,"median":-3.293818,"eighty":-2.590871,"marketCap":12100380},{"date":"2024-06-14","current":-2.536364,"twenty":-7.99774,"median":-3.211422,"eighty":-2.574044,"marketCap":11713111},{"date":"2024-06-21","current":-2.409546,"twenty":-7.933831,"median":-3.194759,"eighty":-2.543297,"marketCap":11127455},{"date":"2024-06-28","current":-2.408319,"twenty":-7.915572,"median":-3.18814,"eighty":-2.539819,"marketCap":11121788},{"date":"2024-07-05","current":-2.340001,"twenty":-7.897312,"median":-3.163489,"eighty":-2.517446,"marketCap":10806289},{"date":"2024-07-12","current":-2.148137,"twenty":-7.860792,"median":-3.149795,"eighty":-2.484198,"marketCap":9920249},{"date":"2024-07-15","current":-2.063455,"twenty":-7.842533,"median":-3.149795,"eighty":-2.476543,"marketCap":9529182},{"date":"2024-08-02","current":-1.8,"twenty":-7.824273,"median":-3.149795,"eighty":-2.472639,"marketCap":8312530},{"date":"2024-08-09","current":-1.490993,"twenty":-7.627068,"median":-3.134046,"eighty":-2.438304,"marketCap":6885510},{"date":"2024-08-16","current":-1.275527,"twenty":-7.359564,"median":-3.024259,"eighty":-2.416511,"marketCap":6059653},{"date":"2024-08-23","current":-0.996722,"twenty":-6.536966,"median":-2.921549,"eighty":-2.408074,"marketCap":4735130},{"date":"2024-08-30","current":-1.174958,"twenty":-5.249658,"median":-2.921549,"eighty":-2.362653,"marketCap":5581877},{"date":"2024-09-06","current":-1.375091,"twenty":-4.920984,"median":-2.840249,"eighty":-2.345852,"marketCap":6532648},{"date":"2024-09-13","current":-1.357574,"twenty":-4.774907,"median":-2.7913,"eighty":-2.312486,"marketCap":6449430},{"date":"2024-09-20","current":-1.33918,"twenty":-4.674479,"median":-2.751214,"eighty":-2.26391,"marketCap":6362050},{"date":"2024-09-27","current":-0.556488,"twenty":-4.272766,"median":-2.706294,"eighty":-1.721618,"marketCap":2643710},{"date":"2024-10-04","current":-0.825353,"twenty":-3.907572,"median":-2.663183,"eighty":-1.516044,"marketCap":3921009},{"date":"2024-10-11","current":-0.609011,"twenty":-3.809883,"median":-2.623475,"eighty":-1.448755,"marketCap":2893229},{"date":"2024-10-18","current":-0.543983,"twenty":-3.700324,"median":-2.618669,"eighty":-1.401366,"marketCap":2584301},{"date":"2024-10-25","current":-0.958273,"twenty":-3.624547,"median":-2.598328,"eighty":-1.356698,"marketCap":4552470},{"date":"2024-10-31","current":-0.965548,"twenty":-3.591497,"median":-2.58341,"eighty":-1.330061,"marketCap":4587034},{"date":"2024-11-08","current":-0.186042,"twenty":-3.543017,"median":-2.570883,"eighty":-1.290658,"marketCap":883831},{"date":"2024-11-15","current":-0.272307,"twenty":-3.520466,"median":-2.545057,"eighty":-1.259215,"marketCap":1293652},{"date":"2024-11-22","current":-1.912035,"twenty":-3.514988,"median":-2.532982,"eighty":-1.195453,"marketCap":10456757},{"date":"2024-11-29","current":-0.970216,"twenty":-3.514075,"median":-2.507089,"eighty":-1.176604,"marketCap":5306027},{"date":"2024-12-06","current":-0.979681,"twenty":-3.507684,"median":-2.495456,"eighty":-1.057426,"marketCap":5357793},{"date":"2024-12-13","current":-1.055406,"twenty":-3.495725,"median":-2.476318,"eighty":-1.052022,"marketCap":5771922},{"date":"2024-12-20","current":-1.320411,"twenty":-3.487233,"median":-2.449166,"eighty":-1.053364,"marketCap":7221213},{"date":"2024-12-27","current":-1.354124,"twenty":-3.469339,"median":-2.436446,"eighty":-1.055406,"marketCap":7405585},{"date":"2025-01-03","current":-1.393455,"twenty":-3.460209,"median":-2.417636,"eighty":-1.071656,"marketCap":7620685},{"date":"2025-01-10","current":-1.18556,"twenty":-3.45108,"median":-2.415433,"eighty":-1.087177,"marketCap":6483728},{"date":"2025-01-17","current":-1.208035,"twenty":-3.441037,"median":-2.409546,"eighty":-1.102066,"marketCap":6606642},{"date":"2025-01-24","current":-1.112516,"twenty":-3.431907,"median":-2.407092,"eighty":-1.109145,"marketCap":6084256},{"date":"2025-01-31","current":-0.955191,"twenty":-3.419127,"median":-2.368422,"eighty":-1.085209,"marketCap":5223856},{"date":"2025-02-07","current":-1.039472,"twenty":-3.407716,"median":-2.352273,"eighty":-1.05223,"marketCap":5684785},{"date":"2025-02-14","current":-0.955191,"twenty":-3.391736,"median":-2.340001,"eighty":-1.033105,"marketCap":5223856},{"date":"2025-02-21","current":-0.915859,"twenty":-3.378041,"median":-2.326586,"eighty":-0.998824,"marketCap":5008756},{"date":"2025-02-28","current":-0.668633,"twenty":-3.378041,"median":-2.304429,"eighty":-0.984457,"marketCap":3656699},{"date":"2025-03-07","current":-0.406293,"twenty":-3.378041,"median":-2.256137,"eighty":-0.973171,"marketCap":2221982},{"date":"2025-03-14","current":-0.413918,"twenty":-3.37165,"median":-2.063455,"eighty":-0.968145,"marketCap":2263682},{"date":"2025-03-21","current":-0.675785,"twenty":-3.34426,"median":-1.851285,"eighty":-0.96081,"marketCap":3695808},{"date":"2025-03-28","current":-0.778466,"twenty":-3.336318,"median":-1.604046,"eighty":-0.955191,"marketCap":4257365},{"date":"2025-04-04","current":-0.500407,"twenty":-3.333578,"median":-1.540289,"eighty":-0.934537,"marketCap":3125408},{"date":"2025-04-11","current":-0.363417,"twenty":-3.331022,"median":-1.490993,"eighty":-0.836712,"marketCap":2269810},{"date":"2025-04-17","current":-0.292093,"twenty":-3.323718,"median":-1.4582,"eighty":-0.778466,"marketCap":1824333},{"date":"2025-04-25","current":-0.251335,"twenty":-3.263918,"median":-1.443055,"eighty":-0.679871,"marketCap":1569775},{"date":"2025-05-02","current":-0.270582,"twenty":-3.218269,"median":-1.417569,"eighty":-0.675289,"marketCap":1689983},{"date":"2025-05-09","current":-0.266053,"twenty":-3.204574,"median":-1.39741,"eighty":-0.646723,"marketCap":1661699},{"date":"2025-05-16","current":-0.262826,"twenty":-3.194988,"median":-1.384287,"eighty":-0.595535,"marketCap":1697054},{"date":"2025-05-23","current":-0.3205,"twenty":-3.194531,"median":-1.364277,"eighty":-0.557113,"marketCap":2069451},{"date":"2025-05-30","current":-0.451578,"twenty":-3.184305,"median":-1.354754,"eighty":-0.542732,"marketCap":2915816},{"date":"2025-06-06","current":-0.457969,"twenty":-3.174445,"median":-1.33918,"eighty":-0.520246,"marketCap":2957077},{"date":"2025-06-13","current":-0.462229,"twenty":-3.158012,"median":-1.322196,"eighty":-0.515702,"marketCap":2984585},{"date":"2025-06-20","current":-0.447318,"twenty":-3.151895,"median":-1.320411,"eighty":-0.500505,"marketCap":2888308},{"date":"2025-06-27","current":-0.462229,"twenty":-3.149977,"median":-1.313781,"eighty":-0.487953,"marketCap":2984585},{"date":"2025-07-03","current":-0.477139,"twenty":-3.149795,"median":-1.303555,"eighty":-0.473305,"marketCap":3080862},{"date":"2025-07-11","current":-0.48353,"twenty":-3.149247,"median":-1.292317,"eighty":-0.477139,"marketCap":3122123},{"date":"2025-07-18","current":-0.48779,"twenty":-3.145321,"median":-1.284002,"eighty":-0.477139,"marketCap":3149631},{"date":"2025-07-25","current":-0.49205,"twenty":-3.13537,"median":-1.275385,"eighty":-0.477991,"marketCap":3177139},{"date":"2025-08-01","current":-0.445188,"twenty":-3.121036,"median":-1.227076,"eighty":-0.474583,"marketCap":2874554},{"date":"2025-08-06","current":-0.398326,"twenty":-3.111449,"median":-1.221257,"eighty":-0.470749,"marketCap":2571969}],"updateTime":1754602846777}}}